Moderna, Inc. (MRNA)

$229.39+8.56 (+3.88%) Set alert

Data as of Nov 3, 9:50 AM ETPrices may be delayedHow our data works

SMA

Res / Sup are automatic swing levels for educational reference only — not signals or advice.

Prices may be delayed. For informational purposes only — not investment advice.

MRNA key stats

Market cap
$88.52B
P/E (TTM)
—
52-week range
$22.28 – $254.48
Volume
1.61M
Prev close
$220.83
Day range
$220.23 – $233.32
EPS (TTM)
$-7.98
Industry
Biological Products, (No Diagnostic Substances)
67

MRNA GlowScore: Active

A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.

Track GlowScore free

About Moderna, Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

What's moving MRNA today

Updated November 3, 2026

As of November 3, 2026, Moderna, Inc. (MRNA) stock climbed to $229.39, up 3.88% (+$8.56) versus the previous close. On the day, shares have traded between $220.23 and $233.32. That puts MRNA in the upper third of its 52-week range of $22.28 to $254.48. Moderna, Inc. operates in the biological products, (no diagnostic substances) space and carries a market capitalization of roughly $88.16 billion, with about 1.61 million shares changing hands.

Latest MRNA news

Source: Yahoo Finance RSS · Updated November 3, 2026

Want MRNA headlines, alerts and AI research in one place? Create a free account →

MRNA buzz on Stocktwits

117,669 watchers
Bullish 11tagged in last 30 postsBearish 3
  • $SLS $MRNA Per the SAP approved by the Fda November 2022, ALL GPS NEEDS IS ≤ .636 and its worth $40B to Big Pharma.

    @55X_ROI_Q1_2026· Nov 3, 9:50 AM ET

  • $MRNA who thinks it is a dead cat bounce?

    @TradesWithTom· Nov 3, 9:48 AM ET

  • $MRNA getting very juicy for a short again. Short naked calls for now for 300+

    @LongerThanLong· Nov 3, 9:47 AM ET· Bearish

  • $MRNA The Fall is coming….

    @BullTMC· Nov 3, 9:46 AM ET· Bearish

  • $INO $MRNA $RVMD $SLS As of 2026-11-03 09:25:23 AM EST, there were 4,000 shares available with a fee of 5.69%. Warrants are almost Extinguished going in to one ☝️ of the biggest Oncology readouts in a Millenia. ✌️🙏❤️‍🩹

    @SellasgpsCurativeBAT11· Nov 3, 9:44 AM ET· Bullish

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →

MRNA Congress & insider trades

Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.

All MRNA insider filings →

AI research on MRNA

Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.

Live movers & big gappers

See the biggest daily gainers, losers and premarket gappers across the market, updated live.

Track MRNA like a pro — free

Create a free GlowTicker account to build your watchlist, get AI research, live movers and price alerts. Upgrade to PRO anytime for the full firehose.

Live charts AI research Price alerts

Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.

Popular stocks